» Authors » Kazuma Sugie

Kazuma Sugie

Explore the profile of Kazuma Sugie including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 152
Citations 754
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mano T, Kobayashi Y, Asada K, Goka K, Iwasa N, Kinugawa K, et al.
Medicine (Baltimore) . 2025 Mar; 104(10):e41705. PMID: 40068081
Objective: Patients with cerebrovascular disease tend to exhibit patterned hemiplegia, such as the Wernicke-Mann posture. Delayed cessation of synkinesis is a major factor impeding hemiplegic recovery; however, effective rehabilitation for...
2.
Nishimori Y, Tanboon J, Oyama M, Motegi H, Tomo Y, Oba M, et al.
J Neurol . 2025 Feb; 272(3):206. PMID: 39954092
It is still unknown whether anti-mitochondrial M2 antibody (AM2A)-positive myositis is an independent subtype of autoimmune myositis (AIM). As such, the aim of this study is to better characterize the...
3.
Ohira M, Takano A, Yoshi K, Arai A, Aso Y, Furutani R, et al.
Eur J Neurol . 2025 Jan; 32(1):e70005. PMID: 39807698
Background And Purpose: Clinical manifestations of Lyme borreliosis (LB), caused by Borrelia burgdorferi sensu lato (Bbsl), include erythema migrans, Lyme neuroborreliosis (LNB), carditis, and arthritis. LB is a notifiable disease...
4.
Kataoka H, Nanaura H, Sugie K
Encephalitis . 2025 Jan; 5(1):6-14. PMID: 39788114
Purpose: The etiology of encephalitis is unknown in 40%-50% of cases, so a comprehensive examination of encephalitis would be significant and meaningful. The short-term outcomes in appropriately managed patients are...
5.
Nakamura A, Matsumura T, Ogata K, Mori-Yoshimura M, Takeshita E, Kimura K, et al.
Neurol Genet . 2024 Dec; 11(1):e200215. PMID: 39712290
Background And Objectives: Becker muscular dystrophy (BMD) is an allelic disorder of Duchenne muscular dystrophy (DMD) in which pathogenic variants in cause progressive worsening of motor dysfunction, muscle weakness and...
6.
Kataoka H, Isogawa M, Nanaura H, Kurakami H, Hasebe M, Kinugawa K, et al.
Clin Park Relat Disord . 2024 Dec; 11:100285. PMID: 39650051
Introduction: Zonisamide is a medication developed in Japan that is effective for motor symptoms and wearing off in Parkinson's disease (PD). Zonisamide has properties that may improve sleep disorders. The...
7.
Awano H, Nambu Y, Osawa K, Shirakawa T, Matsumura T, Wakisaka A, et al.
Clin Chim Acta . 2024 Nov; 566:120053. PMID: 39561886
Background: Becker muscular dystrophy (BMD) is a dystrophinopathy caused by a pathological variant of the DMD gene. Urinary titin, a degradation product of the giant protein titin present in muscle...
8.
Kinugawa K, Mano T, Sugie K
Sci Rep . 2024 Nov; 14(1):27333. PMID: 39521853
Parkinson's disease (PD) is characterized by motor and non-motor symptoms. Cognitive decline is crucial in disease progression and affect quality of life; however, their underlying mechanisms in PD remain unclear....
9.
Imamura K, Izumi Y, Egawa N, Ayaki T, Nagai M, Nishiyama K, et al.
BMJ Open . 2024 Oct; 14(10):e082142. PMID: 39461864
Introduction: Amyotrophic lateral sclerosis (ALS) is a progressive, severe neurodegenerative disease caused by motor neuron death. Development of a medicine for ALS is urgently needed, and induced pluripotent cell-based drug...
10.
Sugie K, Nishino I
Biomolecules . 2024 Oct; 14(10). PMID: 39456205
Danon disease, an X-linked dominant vacuolar cardiomyopathy and skeletal myopathy, is caused by a primary deficiency of lysosome-associated membrane protein-2 (LAMP-2). This disease is one of the autophagy-related muscle diseases....